From owner-molreps@hgmp.mrc.ac.uk  Mon Nov  1 11:15:22 1999
Return-Path: <owner-molreps@hgmp.mrc.ac.uk>
Delivered-To: molreps-archive@hgmp.mrc.ac.uk
Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110)
	id 6F85017A62; Mon,  1 Nov 1999 11:15:21 +0000 (GMT)
Received: from niobium.hgmp.mrc.ac.uk (niobium [193.62.192.41])
	by hgmp.mrc.ac.uk (8.9.3/8.9.3) with ESMTP id LAA08291
	for <molreps-list@hgmp.mrc.ac.uk>; Mon, 1 Nov 1999 11:15:19 GMT
Received: (from news@localhost)
	by niobium.hgmp.mrc.ac.uk (8.9.3+Sun/8.8.8) id LAA00583
	for molreps-list@hgmp.mrc.ac.uk; Mon, 1 Nov 1999 11:15:18 GMT
X-Authentication-Warning: niobium.hgmp.mrc.ac.uk: news set sender to <news> using -f
From: BIOSCI Administrator <biohelp@net.bio.net>
X-Newsgroups: bionet.molecules.repertoires
Subject: BIOSCI/bionet miniFAQ & Fundraiser
Date: 1 Nov 1999 02:55:54 -0800
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 242
Distribution: world
Message-ID: <199910280900.CAA10051@net.bio.net>
To: molreps@hgmp.mrc.ac.uk
Sender: owner-molreps@hgmp.mrc.ac.uk
Precedence: bulk


(LAST REVISION: 14-AUG-99)

This BIOSCI "miniFAQ" is designed to answer the questions that come up
the *most frequently*.  The main BIOSCI FAQ (Frequently Asked
Questions) is accessible on the World Wide Web at URL
http://www.bio.net/.

If you can not find an answer to your question in this or other
documentation, the BIOSCI technical support staff answers e-mail
queries sent to

		       biosci-help@net.bio.net

We can only answer questions about the use of the newsgroups and
mailing lists.  We unfortunately do not have the staff to do Internet
information searches or answer scientific questions.  Please post
those to the appropriate BIOSCI/bionet newsgroups.


	Contents:
	--------
	0) BIOSCI NEEDS YOUR SUPPORT!!

	1) Using the WWW to access the BIOSCI/bionet newsgroups.

	2) What to do about "spams," i.e., junk mail, ads, etc.

	3) Examples of subscribing and unsubscribing to the mailing lists.

	4) The BIOSCI user address and research interest directory.


0) BIOSCI NEEDS YOUR SUPPORT!!
------------------------------
BIOSCI's government funding has been expended, and we are now
operating solely from advertising revenue that we have raised from our
Web site at http://www.bio.net/.  We need just a few minutes of your
time to help us serve you.

You can do two important things which will take very little time for
you individually and will immensely help us continue to help you.

First, please use our WWW system at http://www.bio.net/ to access the
archives.  You can post or reply to messages via your Web browser as
described in item #1 below.  Your usage helps attract sponsors. If you
contact any of our sponsors, please be sure to thank them for
supporting BIOSCI. It is critical for them to get this feedback if
they are to continue their sponsorship for the long term.

Second, if you work for a company or organization that provides
products or services of interest to the biology community, please pass
this message on to your marketing or marketing communications
department or other appropriate group.  Please ask them to help
support BIOSCI by sponsoring our Web site and explain the uses and
benefits of the system to the biology community. If they are
interested, they can then contact us for further information at our
tech support address, biosci-help@net.bio.net.


1) Using the WWW to access the BIOSCI/bionet newsgroups.
--------------------------------------------------------
All BIOSCI/bionet full newsgroups are accessible through the World
Wide Web (WWW) at URL http://www.bio.net.  One can read and reply
publicly or privately to both recent postings and archived messages
through one's Web browser if it is configured properly to send e-mail.
Each newsgroup is equipped with its own WAIS index.  The main BIOSCI
home page also has access to the BIO-JOURNALS Table of Contents
database WAIS index and the BIOSCI user address database described in
another item further below.


2) What to do about "spams," i.e., junk mail, ads, etc.
-------------------------------------------------------
BIOSCI is a set of parallel USENET newsgroups (the "bionet" groups),
mailing lists, and a hypermail archive at URL http://www.bio.net/.
The same postings are distributed on all media (except for a small
number of mailing-list-only groups at net.bio.net).  Unfortunately it
is becoming a despicable practice on the Internet (by a few people out
to make a fast buck) to do automated mass postings to thousands of
newsgroups and mailing lists.  These attempts to grab free advertising
are refered to as "spams" in the usual, somewhat boneheaded, net
terminology.  USENET is more susceptible to this practice, and many
spams originate on the USENET groups and then are passed on to the
mailing lists.  However, spammers also get lists of mailing addresses
and hit these too, so neither medium is immune.

What should you do personally if you get junk mail?
---------------------------------------------------
Just delete it and move on without reading it further.  Filing a
protest is becoming increasingly useless because spammers are often
disguising the addresses where the messages are sent from.  Unless you
really understand Internet mail systems, your attempt at protest by
sending replies to the message will often end up being sent to the
address of an innocent person that the spammer is victimizing.

What can BIOSCI/bionet do to protect its newsgroups?
----------------------------------------------------
The only solution currently available is to moderate the newsgroup.
If this newsgroup is already moderated, then you are in good shape.
Moderation protects the USENET distribution from about 95% of the
spams that are being sent to date and protects the mailing lists
completely.  Moderation means, however, that someone has to take the
time to review each message before it goes out.  We have set up
software here that simply allows the moderator to forward to an
address at net.bio.net messages that (s)he wishes to have distributed.
This takes no more time than that needed to read the message and pass
it on, say about 1 min. per message.

Most newsgroups currently have a discussion leader who is responsible
for their newsgroup.  The discussions leaders and their e-mail
addresses are listed in the BIOSCI Information Sheet which is
available on the Web at http://www.bio.net/.  If a newsgroup is being
hit with too many junk postings, please contact the discussion leader
for that group and see if there is interest in moderating the group.
Please do not assume that by simply posting a complaint to the
newsgroup itself, anyone on the BIOSCI staff will act on your
complaint.  With close to 100 newsgroups to run, the BIOSCI staff has
to rely on the discussion leaders of each newsgroup to report problems
directly to us at biosci-help@net.bio.net.

We will moderate any of our newsgroups if the discussion leader tells
us that the readership of the group wishes to do so and if a moderator
is willing to do the work.  For most BIOSCI/bionet groups, this
entails only a few minutes of work each day.

Moderating a newsgroup will resolve probably 95% of the junk postings
on the USENET distribution.  Unfortunately there are easy ways for
determined spammers to override the moderation mechanism on USENET,
but we can protect our e-mail subscribers from unwanted postings if
the newsgroup is moderated.  You can also access our newsgroups over
the WWW at URL http://www.bio.net.  While this Web interface will not
stop spammers from trying to post to the groups, this will give you
yet another way, besides using USENET news, to keep the junk out of
your personal mail files.  For those of you with local USENET news
systems, the Web interface will also give you faster access to new
newsgroups and recent postings.


3) Examples of subscribing and unsubscribing to the mailing lists.
------------------------------------------------------------------
PLEASE NOTE: The BIOSCI management does NOT act on
subscription/unsubscription requests that are posted improperly to the
newsgroups and mailing lists.  People who do this only bother everyone
on the lists to no avail.  Please be sure to follow the proper
procedures below.

Gory details are in the BIOSCI Information sheets on the Web at
http://www.bio.net.  Below we give an example utilizing the
METHODS-AND-REAGENTS list at both of our two BIOSCI sites:

Users in the Americas and Pacific Rim countries who use the BIOSCI
------------------------------------------------------------------
node at computer net.bio.net:
----------------------------

A) Determine the "listname" which is the <=8 character mail address
                                         ^^^^^^^^^^^^^
   for the group.  These can be found in the BIOSCI Info. Sheet.  For
   the METHODS-AND-REAGENTS group the mailing address is
   methods@net.bio.net.  The listname is the portion of the address to
   the left of the @ sign, i.e., "methods".  The listname is used with
   the "subscribe" and "unsubscribe" commands illustrated below.

B) Mail all commands in the body of a mail message addressed to
   biosci-server@net.bio.net.  Do NOT send commands to the newsgroup
   posting addresses!  Leave the Subject: line blank, any text on it
   will be ignored.

C) In the body of your message put one or more of the following
   commands with an "end" command on the last line, e.g.,

   subscribe methods
   unsubscribe methods
   end

   Do NOT put your e-mail address or other text on these lines.  The
   server only allows you to cancel your subscription if the address
   on your mail header matches the address on our mailing list.
   Please ask for help at biosci-help@net.bio.net if your address has
   changed, e.g., if you know you are on the list but the server tells
   you that you are not a member.


Users in Europe, Africa, and Central Asia who use the BIOSCI node at
--------------------------------------------------------------------
the UK-HGMP-Resource Centre (known as hgmp.mrc.ac.uk):
-----------------------------------------------------

A) Determine the "listname" which is the <=8 character mail address
                                         ^^^^^^^^^^^^^
   for the group.  These can be found in the BIOSCI Info. Sheet.  For
   the METHODS-AND-REAGENTS group the mailing address is
   methods@hgmp.mrc.ac.uk.  The listname is the portion of the address to
   the left of the @ sign, i.e., "methods".  The listname is used with
   the "subscribe" and "unsubscribe" commands illustrated below.

B) Mail all commands in the body of a mail message addressed to
   majordomo@hgmp.mrc.ac.uk.  Do NOT send commands to the newsgroup
   posting addresses!  Leave the Subject: line blank, any text on it
   will be ignored.

C) In the body of your message put one or more of the following
   commands with an "end" command on the last line, e.g.,

   subscribe methods
   unsubscribe methods
   end

   Please ask for help at biosci@hgmp.mrc.ac.uk if your address has
   changed, e.g., if you know you are on the list but the server tells
   you that you are not a member.


4) The BIOSCI user address and research interest directory.
-----------------------------------------------------------
Please take this opportunity to add your name, address, and research
interest information to the BIOSCI User Address Database if you have
not already done so.

You can fill out the address form directly through our Web page at URL
http://www.bio.net/adrform.html.

The address database is reindexed nightly for WWW access (the URL is
http://www.bio.net/).  If you are not directly on the Internet but can
reach it by e-mail, please use our waismail server to access the user
directory.  waismail use is described above.  You can also request a
user address form by e-mail from biosci-help@net.bio.net.

Please check your database entry from time-to-time to see if your
address information is still up-to-date.  Because of our limited
personnel resources, we ask that you resubmit a *complete* form to
revise your entry; we only replace complete entries and do not have
resources to edit old forms.










From owner-molreps@hgmp.mrc.ac.uk  Mon Nov  1 12:45:26 1999
Return-Path: <owner-molreps@hgmp.mrc.ac.uk>
Delivered-To: molreps-archive@hgmp.mrc.ac.uk
Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110)
	id E768717A43; Mon,  1 Nov 1999 12:45:25 +0000 (GMT)
Received: from niobium.hgmp.mrc.ac.uk (niobium [193.62.192.41])
	by hgmp.mrc.ac.uk (8.9.3/8.9.3) with ESMTP id MAA14660
	for <molreps-list@hgmp.mrc.ac.uk>; Mon, 1 Nov 1999 12:45:23 GMT
Received: (from news@localhost)
	by niobium.hgmp.mrc.ac.uk (8.9.3+Sun/8.8.8) id MAA01690
	for molreps-list@hgmp.mrc.ac.uk; Mon, 1 Nov 1999 12:45:22 GMT
X-Authentication-Warning: niobium.hgmp.mrc.ac.uk: news set sender to <news> using -f
From: "z. g. zhao" <zzhao@azcc.arizona.edu>
X-Newsgroups: bionet.molecules.repertoires
Subject: Fwd --- new software-
Date: 1 Nov 1999 04:33:01 -0800
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 29
Distribution: world
Message-ID: <3815D4B7.A49AC5FB@azcc.arizona.edu>
To: molreps@hgmp.mrc.ac.uk
Sender: owner-molreps@hgmp.mrc.ac.uk
Precedence: bulk

I would be obliged if you could post the following message on the
list.   I tried direct posting but the message was rejected.
Peter Bladon

----------------------------------------------
Subject          INTERCHEM Software

This is to announce the availability of the latest version of INTERCHEM
Molecular Modelling Software. This includes databases containing 450,000

small molecule structures.

For details see the URL:

http://interchem.chem.strath.ac.uk/inter/interprobe.html

I have aimed this message at several bulletins, so please accept my
apologies if you receive several copies!

Peter Bladon

---------------------------End of Message for
Posting-----------------------








From owner-molreps@hgmp.mrc.ac.uk  Tue Nov  2 16:05:24 1999
Return-Path: <owner-molreps@hgmp.mrc.ac.uk>
Delivered-To: molreps-archive@hgmp.mrc.ac.uk
Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110)
	id 29E1F17A64; Tue,  2 Nov 1999 16:05:23 +0000 (GMT)
Received: from niobium.hgmp.mrc.ac.uk (niobium [193.62.192.41])
	by hgmp.mrc.ac.uk (8.9.3/8.9.3) with ESMTP id QAA25639
	for <molreps-list@hgmp.mrc.ac.uk>; Tue, 2 Nov 1999 16:05:22 GMT
Received: (from news@localhost)
	by niobium.hgmp.mrc.ac.uk (8.9.3+Sun/8.8.8) id QAA00526
	for molreps-list@hgmp.mrc.ac.uk; Tue, 2 Nov 1999 16:05:20 GMT
X-Authentication-Warning: niobium.hgmp.mrc.ac.uk: news set sender to <news> using -f
From: "Dr. Philippe Silar" <silar@igmors.u-psud.fr>
X-Newsgroups: bionet.molecules.repertoires
Subject: reprint request
Date: 2 Nov 1999 07:47:30 -0800
Organization: Institut de =?iso-8859-1?Q?G=E9n=E9tique?= et Microbiologie
Lines: 12
Distribution: world
Message-ID: <381EAFB3.5F62356B@igmors.u-psud.fr>
To: molreps@hgmp.mrc.ac.uk
Sender: owner-molreps@hgmp.mrc.ac.uk
Precedence: bulk

Dear colleague,
 I am unable to get rapidly a reprint of the following paper by  wang et
al. (in J. Nat. Prod. 1997 60(6):629-631; anserinones A and B: new
antifungal, antibacterial benzoquinones from the corpophilous fungus
Podospora anserina). I would be very grateful if somebody can send me a
PDF file of this paper.
Thnak you,
Pr. P. Silar






From owner-molreps@hgmp.mrc.ac.uk  Mon Nov  8 15:11:07 1999
Return-Path: <owner-molreps@hgmp.mrc.ac.uk>
Delivered-To: molreps-archive@hgmp.mrc.ac.uk
Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110)
	id 695C617A8A; Mon,  8 Nov 1999 15:11:06 +0000 (GMT)
Received: from niobium.hgmp.mrc.ac.uk (niobium [193.62.192.41])
	by hgmp.mrc.ac.uk (8.9.3/8.9.3) with ESMTP id PAA05562
	for <molreps-list@hgmp.mrc.ac.uk>; Mon, 8 Nov 1999 15:11:03 GMT
Received: (from news@localhost)
	by niobium.hgmp.mrc.ac.uk (8.9.3+Sun/8.8.8) id PAA04611
	for molreps-list@hgmp.mrc.ac.uk; Mon, 8 Nov 1999 15:11:01 GMT
X-Authentication-Warning: niobium.hgmp.mrc.ac.uk: news set sender to <news> using -f
From: Yoshihisa Inoue <inouey@YOSHITOMI.CO.JP>
X-Newsgroups: bionet.molecules.repertoires
Subject: The 9th Meeting of Japan Combinatorial Chemistry Focus Group (JCCF9)
Date: 8 Nov 1999 06:48:50 -0800
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 110
Distribution: world
Message-ID: <199911050004.JAA15398@gccss2.yoshitomi.co.jp>
To: molreps@hgmp.mrc.ac.uk
Sender: owner-molreps@hgmp.mrc.ac.uk
Precedence: bulk

Dear Netters,

We are pleased to announce that Japan Combinatorial Focus Group, JCCF,
will hold the 9th JCCF Meeting on November 10-11 at Kanagawa Science
Park (KSP) in Kawasaki near Tokyo, Japan.

And we have to say sorry that if you want to present your products
at the booths, all the 30 booths are occupied already. Please try
next meeting in Osaka in April.

****************************************************************
9th Meeting of Japan Combinatorial Chemistry Focus Group
****************************************************************
November 10-11
Kanagawa Science Park (KSP), Kawasaki, Kanagawa, Japan

[Wednesday, November 10]

10:00-10:10  [Opening remark]  (JCCF) Takashi Takahashi

10:10-10:55  IL-1  Strategies for the Synthesis and Characterization of
                Hundreds to Thousands of Discretes
                (GlaxoWellcome) Sam Gerritz

10:55-11:20  O-1   Synthesis of Arginin Vasopressin Antagonist Using
                Combinatorial Chemistry Technology
                (Yamanouchi Pharm.) Hiroyoshi Yamada,* Yoshiaki Shimada,
                Akihiro Tanaka

11:20-12:05  IL-2  Efficient Parallel Synthesis
                (Axys Advanced Technologies) Barry A. Bunin

12:05-14:00     [LUNCH / Vendor demonstration]

14:00-14:25  O-2   The Synthesis of Peptide Mimetics:  A Library of Serine
                Protease Inhibitor
                (Tokyo Inst. Tech.) Takashi Takahashi, Nibuhiro Fuchi,
                * Takayuki Doi (Molecumetics) Michael Kahn

14:25-14:50  O-3   Efficient Strategies Towards Quality Compound Libraries
                and Their Impact in Lead Discovery-and Optimization
                (Polyphor Ltd) Daniel Obrecht,* Christine Abrecht,
                B. Dhanapal, P. Ermert, J.-P. Obrecht, K. Sekanina

14:50-15:15  IL-3 title to be announced
                (Shanghai Institute of Materia Medica) Jing-Kang Shen

15:15-15:25     refresh time

15:25-15:50  O-4   Organic Synthesis Based on Affinity Separation
                (Osaka Univ.) Koichi Fukase*, San-qi Zhang, Shoichi Kusumoto

15:50-16:50  IL-4  Recyclable Polymer Supported Chiral Auxiliaries
                (Oxford Univ.) Stephen G. Davies

17:00- mixer


[Thursday, November 11]

09:30-10:15  IL-5  The Importance of New Technology in Accelerating Drug
                Discovery: Automation, Informatics and Parallel Synthesis
                (Cambridge Discovery)David Tapolczay

10:15-10:40  O-5   Automated Exact Mass Measurement of Combinatorial
                Libraries by ESI-TOF-MS
                (JASCO International Co.) Hideto Kakimi,* Sanae Furusho

10:40-11:05  O-6   Identification and Optimization of Drug-Like Leads
                (Tripos, Inc.) Edward Hodgkin

11:05-11:50  IL-6  Novel Approach to the Development of Drugs that Target
                Transcription Factors
                (Tokyo Inst. Tech.) Hiroshi Handa

11:50-14:00     [LUNCH / Vendor demonstration]

14:00-14:25  O-7   Library Registration & Design Using Chem-X
                (Oxford Molecular) Stephen J. Cato

14:25-14:50  O-8   Managing the Workflow of a High-Throughput Organic
                Synthesis Laboratory: A Marriage of Automation and
                Information Management Technologies.
                (Molecumetics) Burt Goodman

14:50-15:15  O-9   Click Chemistry: Process Driven Drug Discovery
                (Coelacanth) Hartmuth Kolb

15:15-16:00  IL-6  Palladium Catalysis in Water:  A Combinatorial
                Approach to Water-Based Catalytic Asymmetric Reactions
                (Nagoya City Univ.) Yasuhiro Uozumi

16:00-       [Closing remark]  (JCCF) Koichi Fukase

For details, please visit the JCCF homepage.
The URL is http://www.orgsyn.riken.go.jp/CombiChem.html.
FAX:+81(Japan)-6-6443-6685
Email: jccf@yo.rim.or.jp

 \   /    _   /   / Yoshihisa INOUE,  Yoshitomi Pharcaceut.Ind., Ltd.
  \ /    /   /   /  2-25-1 Shodai-Ohtani,Hirakata,Osaka 573-1153 JAPAN
   /    ____/   /   tel: +81-720-56-9328
  /    /       /    fax: +81-720-68-9597
_/  __/     __/     E-mail: inouey@yoshitomi.co.jp








From owner-molreps@hgmp.mrc.ac.uk  Mon Nov  8 19:25:21 1999
Return-Path: <owner-molreps@hgmp.mrc.ac.uk>
Delivered-To: molreps-archive@hgmp.mrc.ac.uk
Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110)
	id 9D11C17A60; Mon,  8 Nov 1999 19:25:20 +0000 (GMT)
Received: from niobium.hgmp.mrc.ac.uk (niobium [193.62.192.41])
	by hgmp.mrc.ac.uk (8.9.3/8.9.3) with ESMTP id TAA22209
	for <molreps-list@hgmp.mrc.ac.uk>; Mon, 8 Nov 1999 19:25:17 GMT
Received: (from news@localhost)
	by niobium.hgmp.mrc.ac.uk (8.9.3+Sun/8.8.8) id TAA07944
	for molreps-list@hgmp.mrc.ac.uk; Mon, 8 Nov 1999 19:25:16 GMT
X-Authentication-Warning: niobium.hgmp.mrc.ac.uk: news set sender to <news> using -f
From: Shu-Kun Lin <lin@mdpi.org>
X-Newsgroups: bionet.molecules.repertoires
Subject: MolMall - Rare Chemical Samples Database on the Internet
Date: 8 Nov 1999 09:18:42 -0800
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 33
Distribution: world
Message-ID: <382329B3.C309AC63@mdpi.org>
To: molreps@hgmp.mrc.ac.uk
Sender: owner-molreps@hgmp.mrc.ac.uk
Precedence: bulk

You may easily search for samples you need at
MolMall (http://www.molmall.org), the Rare Chemical Samples Exchange
Center. You may do full structure search or substructure search
on the website. You may search for name of the submitter. E.g.,
at "Power Search", you put LIN as the query, you will find
a list of 8 structures (Lin contributed 8 samples). There other
very useful searching functions. More detailed data sheet regarding
a sample is available by clicking on the number.

Direct link to published paper was made. However, so
far there are only links to Molecules MolBank (http://www.molbank.org)
papers if the compounds are published there.

We also plan to allow he sample submitters to add additional information
to the data sheet, such as the literature where the compound
was published. Any suggestions?

Have fun!

Shu-Kun

--
Dr. Shu-Kun Lin
Molecular Diversity Preservation International (MDPI)
Saengergasse 25, CH-4054 Basel, Switzerland
Tel. +41 79 322 3379, Fax +41 61 302 8918
E-mail: lin@mdpi.org
http://www.mdpi.org/lin/







From owner-molreps@hgmp.mrc.ac.uk  Mon Nov  8 23:40:10 1999
Return-Path: <owner-molreps@hgmp.mrc.ac.uk>
Delivered-To: molreps-archive@hgmp.mrc.ac.uk
Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110)
	id EFB5E17A60; Mon,  8 Nov 1999 23:40:09 +0000 (GMT)
Received: from niobium.hgmp.mrc.ac.uk (niobium [193.62.192.41])
	by hgmp.mrc.ac.uk (8.9.3/8.9.3) with ESMTP id XAA06397
	for <molreps-list@hgmp.mrc.ac.uk>; Mon, 8 Nov 1999 23:40:04 GMT
Received: (from news@localhost)
	by niobium.hgmp.mrc.ac.uk (8.9.3+Sun/8.8.8) id XAA19272
	for molreps-list@hgmp.mrc.ac.uk; Mon, 8 Nov 1999 23:40:03 GMT
X-Authentication-Warning: niobium.hgmp.mrc.ac.uk: news set sender to <news> using -f
From: "Dr. Wendy A. Warr" <wendy@warr.com>
X-Newsgroups: bionet.molecules.repertoires
Subject: News items
Date: 8 Nov 1999 06:44:25 -0800
Organization: BIOSCI International Newsgroups for Molecular Biology
Distribution: world
Message-ID: <3821DEBC.4622@warr.com>
Lines: 32
To: molreps@hgmp.mrc.ac.uk
Sender: owner-molreps@hgmp.mrc.ac.uk
Precedence: bulk

Some recent news items at http://www.warr.com/warrzone.htm

Argonaut and Symyx Sell Instruments for Combinatorial Chemistry
Spotfire and Oxford Molecular Group Integrate Software
Oxford Molecular launches RS3 Discovery for Excel
Cambridge Combinatorial Announces Name Change
Alliance of Cambridge Discovery Chemistry and Lancaster Synthesis
News from LHASA Ltd
Intranet International 2000: a New Conference Announced
Annual General Meeting of the Pharma Documentation Ring
Roche, Parke-Davis and Ribotargets Award Additional Contracts To
Biofocus
Annual Reports in Combinatorial Chemistry and Molecular Diversity
ChemConnect Announces Successful Second Round of Capital Funding
Beilstein Abstracts Now Free of Charge to Members of ChemWeb.com
ChemWeb Launches Catalysis Forum
New Version of Marvin Java Applets
Latest Issue in the Current Trends Series

Wendy


--
Dr Wendy A Warr
Wendy Warr & Associates, 6 Berwick Court
Holmes Chapel, Cheshire CW4 7HZ, England
Tel/fax +44 (0)1477 533837
wendy@warr.com   http://www.warr.com






From owner-molreps@hgmp.mrc.ac.uk  Tue Nov  9 10:42:59 1999
Return-Path: <owner-molreps@hgmp.mrc.ac.uk>
Delivered-To: molreps-archive@hgmp.mrc.ac.uk
Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110)
	id D950217A61; Tue,  9 Nov 1999 10:42:58 +0000 (GMT)
Received: from niobium.hgmp.mrc.ac.uk (niobium [193.62.192.41])
	by hgmp.mrc.ac.uk (8.9.3/8.9.3) with ESMTP id KAA06990
	for <molreps-list@hgmp.mrc.ac.uk>; Tue, 9 Nov 1999 10:42:56 GMT
Received: (from news@localhost)
	by niobium.hgmp.mrc.ac.uk (8.9.3+Sun/8.8.8) id KAA27406
	for molreps-list@hgmp.mrc.ac.uk; Tue, 9 Nov 1999 10:42:55 GMT
X-Authentication-Warning: niobium.hgmp.mrc.ac.uk: news set sender to <news> using -f
From: Daniel Keppler <dkeppler@med.wayne.edu>
X-Newsgroups: bionet.molecules.repertoires
Subject: Re: BclI endonuclease
Date: 9 Nov 1999 02:33:42 -0800
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 25
Distribution: world
Message-ID: <0.000135A5@listserv.rl.ac.uk>
To: molreps@hgmp.mrc.ac.uk
Sender: owner-molreps@hgmp.mrc.ac.uk
Precedence: bulk

Bcl-I is methylation sensitive; try using dam- bacteria.

Yung Kim wrote:
>
> Hi,
>
> In our lab we are using BclI restriction enzyme to cut  a plasmid,  but  somehow we failed with a couple of newly purchased BclI enzymes, although  it was confirmed that the enzyme recognition site is intact  through sequencing.  Does anyone have experience with BclI or suggestion?  I'll appreciate your advice.
>
> Yung Hae Kim
> Oral Molecular Biology
> Oregon Health Science Univ.

--
Daniel Keppler, Ph.D.            Tel.:    (313) 577-0514 (office)
Assistant Professor                       (313) 577-0941 (laboratory)
Department of Pharmacology and   Fax:     (313) 577-6739 (department)
Karmanos Cancer Institute        E-mail:  dkeppler@med.wayne.edu
Wayne State University           Internet:http://www.med.wayne.edu/pharm/
School of Medicine
540 E. Canfield Avenue
Detroit, MI 48201






From owner-molreps@hgmp.mrc.ac.uk  Tue Nov  9 16:07:05 1999
Return-Path: <owner-molreps@hgmp.mrc.ac.uk>
Delivered-To: molreps-archive@hgmp.mrc.ac.uk
Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110)
	id 1BAFF17A43; Tue,  9 Nov 1999 16:07:03 +0000 (GMT)
Received: from niobium.hgmp.mrc.ac.uk (niobium [193.62.192.41])
	by hgmp.mrc.ac.uk (8.9.3/8.9.3) with ESMTP id QAA03105
	for <molreps-list@hgmp.mrc.ac.uk>; Tue, 9 Nov 1999 16:07:00 GMT
Received: (from news@localhost)
	by niobium.hgmp.mrc.ac.uk (8.9.3+Sun/8.8.8) id QAA02411
	for molreps-list@hgmp.mrc.ac.uk; Tue, 9 Nov 1999 16:06:59 GMT
X-Authentication-Warning: niobium.hgmp.mrc.ac.uk: news set sender to <news> using -f
From: Yung Kim <kimyu@OHSU.EDU>
X-Newsgroups: bionet.molecules.repertoires
Subject: BclI endonuclease
Date: 9 Nov 1999 02:27:38 -0800
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 15
Distribution: world
Message-ID: <199911081829.SAA00830@fujin.qub.ac.uk>
To: molreps@hgmp.mrc.ac.uk
Sender: owner-molreps@hgmp.mrc.ac.uk
Precedence: bulk

Hi,

In our lab we are using BclI restriction enzyme to cut  a plasmid,  
but somehow we failed with a couple of newly purchased BclI enzymes, 
although it was confirmed that the enzyme recognition site is intact 
through sequencing. Does anyone have experience with BclI or 
suggestion?  I'll appreciate your advice.

Yung Hae Kim
Oral Molecular Biology
Oregon Health Science Univ.






From owner-molreps@hgmp.mrc.ac.uk  Fri Nov 12 12:15:40 1999
Return-Path: <owner-molreps@hgmp.mrc.ac.uk>
Delivered-To: molreps-archive@hgmp.mrc.ac.uk
Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110)
	id DE90217A67; Fri, 12 Nov 1999 12:15:35 +0000 (GMT)
Received: from niobium.hgmp.mrc.ac.uk (niobium [193.62.192.41])
	by hgmp.mrc.ac.uk (8.9.3/8.9.3) with ESMTP id MAA19758
	for <molreps-list@hgmp.mrc.ac.uk>; Fri, 12 Nov 1999 12:15:29 GMT
Received: (from news@localhost)
	by niobium.hgmp.mrc.ac.uk (8.9.3+Sun/8.8.8) id MAA16871
	for molreps-list@hgmp.mrc.ac.uk; Fri, 12 Nov 1999 12:15:28 GMT
X-Authentication-Warning: niobium.hgmp.mrc.ac.uk: news set sender to <news> using -f
From: Marcel Dinger <marcel@ihug.co.nz>
X-Newsgroups: bionet.molecules.repertoires
Subject: Genamics JournalSeek
Date: 12 Nov 1999 04:03:29 -0800
Organization: The Internet Group (Hamilton)
Lines: 19
Distribution: world
Message-ID: <942347887.772776@ham.ihug.co.nz>
To: molreps@hgmp.mrc.ac.uk
Sender: owner-molreps@hgmp.mrc.ac.uk
Precedence: bulk

GENAMICS JOURNALSEEK
The largest journal information database on Earth.
Check it out now at: http://genamics.com/journals/

Genamics JournalSeek is a fully searchable database of journal information.
JournalSeek now contains over 8500 journal titles. Information includes
abbreviated titles, aims and scope, publisher, link to online site, availability
of abstracts/full-text online, ISSNs, and journal impact factors.

All information is freely provided.

Marcel Dinger,
Genamics.
http://genamics.com







From owner-molreps@hgmp.mrc.ac.uk  Mon Nov 15 21:42:11 1999
Return-Path: <owner-molreps@hgmp.mrc.ac.uk>
Delivered-To: molreps-archive@hgmp.mrc.ac.uk
Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110)
	id 50D4717A8A; Mon, 15 Nov 1999 21:42:11 +0000 (GMT)
Received: from niobium.hgmp.mrc.ac.uk (niobium [193.62.192.41])
	by hgmp.mrc.ac.uk (8.9.3/8.9.3) with ESMTP id VAA09745
	for <molreps-list@hgmp.mrc.ac.uk>; Mon, 15 Nov 1999 21:42:09 GMT
Received: (from news@localhost)
	by niobium.hgmp.mrc.ac.uk (8.9.3+Sun/8.8.8) id VAA18977
	for molreps-list@hgmp.mrc.ac.uk; Mon, 15 Nov 1999 21:42:09 GMT
X-Authentication-Warning: niobium.hgmp.mrc.ac.uk: news set sender to <news> using -f
From: Mark Suter <msuter@vetvir.unizh.ch>
X-Newsgroups: bionet.molecules.repertoires
Subject: Postdoctoral position to study immune response against herpesvirus.
Date: 15 Nov 1999 13:22:23 -0800
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 40
Distribution: world
Message-ID: <l03130302b4509d71c1e5@[130.60.97.19]>
To: molreps@hgmp.mrc.ac.uk
Sender: owner-molreps@hgmp.mrc.ac.uk
Precedence: bulk


We study the immune response against herpes simplex virus 1 (HSV-1) and
pseudorabies virus using in vivo (J. Virol. 73:4748) or in vitro dendritic
cell systems (Eur. J. Immunol. 29:3245). Replication competent virus (J.
Virol. 73:4748) or a novel DNA vaccination approach based on the entire
HSV-1 genome deliverd as bacterial artificial chromosome (PNAS, 96: 12697)
are used for immune-stimulation.
Begin:  January 2000; for one year with the possibility for extension .
Salary:  Based on the regulation of the Swiss National Science Foundation.

Interested candidates with a strong background in immunology or molecular
biology, please send CV and bibliography to:

Dr. Mark Suter
University Institute for Virology
Winterthurerstr. 266a
 8057 Zurich SWITZERLAND

Telephone: (+41) 1 6358717
 Faximile : (+41) 1 6358911

mailto:msuter@vetvir.unizh.ch
http://www.unizh.ch/vetvir


                                     \|/
                                    (o o)
________________________________oOo__(_)__oOo_________________________________
    ___/\_    | Mark Suter                    mailto:msuter@vetvir.unizh.ch
   /    o \/| | University Inst.for Virology  http://www.unizh.ch/vetvir
  /        _| | Winterthurerstr. 266a         Telephone: (+41) 1 6358717
 /_/\__/-\/   | 8057 Zurich SWITZERLAND       Faximile : (+41) 1 6358911
______________________________________________________________________________
    If it wasn't for Windows, we wouldn't have anything to compare Mac's to
______________________________________________________________________________







From owner-molreps@hgmp.mrc.ac.uk  Wed Nov 17 09:40:54 1999
Return-Path: <owner-molreps@hgmp.mrc.ac.uk>
Delivered-To: molreps-archive@hgmp.mrc.ac.uk
Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110)
	id 33E1617A63; Wed, 17 Nov 1999 09:40:52 +0000 (GMT)
Received: from niobium.hgmp.mrc.ac.uk (niobium [193.62.192.41])
	by hgmp.mrc.ac.uk (8.9.3/8.9.3) with ESMTP id JAA15957
	for <molreps-list@hgmp.mrc.ac.uk>; Wed, 17 Nov 1999 09:40:50 GMT
Received: (from news@localhost)
	by niobium.hgmp.mrc.ac.uk (8.9.3+Sun/8.8.8) id JAA24787
	for molreps-list@hgmp.mrc.ac.uk; Wed, 17 Nov 1999 09:40:49 GMT
X-Authentication-Warning: niobium.hgmp.mrc.ac.uk: news set sender to <news> using -f
From: Michael Sherrell <grizzlyan@mindspring.com>
X-Newsgroups: bionet.molecules.repertoires
Subject: ABI 3948 for sale
Date: 17 Nov 1999 01:31:12 -0800
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 14
Distribution: world
Message-ID: <003101bf3099$db84b460$d1c9aec7@rossbranch>
To: molreps@hgmp.mrc.ac.uk
Sender: owner-molreps@hgmp.mrc.ac.uk
Precedence: bulk

ABI 3948 available, ~ 2 yrs. old, running well in Midwestern lab,
~US$105,000.

Michael Sherrell
Grizzly Analytical (USA)
707 887 2919/fax 707 887 9834
www.grizzlyanalytical.com

PS -- for other sequencers, synthesizers, mass specs and NMRs, see the
website.






From owner-molreps@hgmp.mrc.ac.uk  Mon Nov 29 12:45:16 1999
Return-Path: <owner-molreps@hgmp.mrc.ac.uk>
Delivered-To: molreps-archive@hgmp.mrc.ac.uk
Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110)
	id 2E6E517A43; Mon, 29 Nov 1999 12:45:15 +0000 (GMT)
Received: from niobium.hgmp.mrc.ac.uk (niobium [193.62.192.41])
	by hgmp.mrc.ac.uk (8.9.3/8.9.3) with ESMTP id MAA09179
	for <molreps-list@hgmp.mrc.ac.uk>; Mon, 29 Nov 1999 12:45:13 GMT
Received: (from news@localhost)
	by niobium.hgmp.mrc.ac.uk (8.9.3+Sun/8.8.8) id MAA05295
	for molreps-list@hgmp.mrc.ac.uk; Mon, 29 Nov 1999 12:45:12 GMT
X-Authentication-Warning: niobium.hgmp.mrc.ac.uk: news set sender to <news> using -f
From: "Dr. Wendy A. Warr" <wendy@warr.com>
X-Newsgroups: bionet.molecules.repertoires
Subject: What is Cheminformatics?
Date: 29 Nov 1999 04:30:41 -0800
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 45
Distribution: world
Message-ID: <38406DAF.2DFE@warr.com>
To: molreps@hgmp.mrc.ac.uk
Sender: owner-molreps@hgmp.mrc.ac.uk
Precedence: bulk

Please excuse duplicate postings.

My thanks to everyone who sent me data, opinions, and job descriptions
for my talk in New Orleans on the discipline of cheminformatics and the
shortage of skilled staff in that field.

I promised to summarize it all for the lists but that is very difficult
in view of the sheer volume of information involved.

About two years ago, many people (including myself) considered that
"cheminformatics" was a nasty neologism. My survey this summer shows
that it is now an established discipline, although the tasks involved,
and even the name of the discipline, are not clearly defined yet.
"Cheminformatics" was preferred to "chemoinformatics" by most
respondents. One company uses "chemiiinformatics". There is still much
distaste for the job title "cheminformatician".

A zipped file of my PowerPoint slides is available on my Web site

http://www.warr.com/

I have been waiting for COMP Division to put all the slides from this
Symposium on the COMP web site at

http://membership.acs.org/C/COMP/

Unfortunately I think that this has not happened - though at least four
of the main headings on that home page give "404 Not Founds", so perhaps
the material is there but temporarily hidden.

My sincere thanks to all of you who helped in this survey.

Wendy
--
Dr Wendy A Warr
Wendy Warr & Associates, 6 Berwick Court
Holmes Chapel, Cheshire CW4 7HZ, England
Tel/fax +44 (0)1477 533837
wendy@warr.com   http://www.warr.com








From owner-molreps@hgmp.mrc.ac.uk  Tue Nov 30 18:15:33 1999
Return-Path: <owner-molreps@hgmp.mrc.ac.uk>
Delivered-To: molreps-archive@hgmp.mrc.ac.uk
Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110)
	id 9712D17A7C; Tue, 30 Nov 1999 18:15:32 +0000 (GMT)
Received: from niobium.hgmp.mrc.ac.uk (niobium [193.62.192.41])
	by hgmp.mrc.ac.uk (8.9.3/8.9.3) with ESMTP id SAA00896
	for <molreps-list@hgmp.mrc.ac.uk>; Tue, 30 Nov 1999 18:15:30 GMT
Received: (from news@localhost)
	by niobium.hgmp.mrc.ac.uk (8.9.3+Sun/8.8.8) id SAA07508
	for molreps-list@hgmp.mrc.ac.uk; Tue, 30 Nov 1999 18:15:28 GMT
X-Authentication-Warning: niobium.hgmp.mrc.ac.uk: news set sender to <news> using -f
From: Peter Butler <peter.butler@WKAP.NL>
X-Newsgroups: bionet.molecules.repertoires
Subject: Molecular Diversity - Available Online
Date: 30 Nov 1999 10:16:18 -0800
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 66
Distribution: world
Message-ID: <SIMEON.9911301638.W@pc749.wkap.nl>
To: molreps@hgmp.mrc.ac.uk
Sender: owner-molreps@hgmp.mrc.ac.uk
Precedence: bulk

We are pleased to announce that the journal "Molecular Diversity" is
available online to Institutional Subscribers.

Please visit the Journal's homepage for further details:
        http://www.wkap.nl/journals/molecular_diversity

Kind regards,
Peter Butler
Publishing Editor
peter.butler@wkap.nl
==================================================================
Some of the consequences/advantages:

* Articles are loaded as character-based PDF files

* Articles available up to 4 weeks in advance of print

* Coverage dates back to 1997 (as available)
        1997-98 issues included with 1999 subscription
rences from: CSA, ChemPort, SilverLinker,
  Web of Science

* Permits powerful fielded searching using Boolean operators


Access:
* Access granted to institutions (regardless of size), not individuals

* Authentication by domain names/IP range: (no IDs/passwords required)

* Authorized users include:
        - faculty (permanent and visiting)
        - staff (full- and part-time)
        - students (full- and part-time)
        - remote users (must access through institution’s registered
        domain name/IP range)

* Campus-wide, simultaneous access


Pricing:
* Priced for content:  electronic costs same as print (no hidden costs)

* Print plus electronic (dual access) available for 20% surcharge


Licensing Models:
* À la carte:  pick and choose any journals, in any combinations of
  print/electronic

* Site licenses:  75+ subscriptions (reduced dual-access surcharges
  available)

* Consortium licenses:
        group--wide holdings access for all participants
        buy-in option for institutions with few subscriptions
        reduced dual-access surcharge available

* Long-term licenses available, including price cap on subscription rate
  increases








From owner-molreps@hgmp.mrc.ac.uk  Tue Nov 30 18:15:33 1999
Return-Path: <owner-molreps@hgmp.mrc.ac.uk>
Delivered-To: molreps-archive@hgmp.mrc.ac.uk
Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 110)
	id ECBBC17A86; Tue, 30 Nov 1999 18:15:32 +0000 (GMT)
Received: from niobium.hgmp.mrc.ac.uk (niobium [193.62.192.41])
	by hgmp.mrc.ac.uk (8.9.3/8.9.3) with ESMTP id SAA00895
	for <molreps-list@hgmp.mrc.ac.uk>; Tue, 30 Nov 1999 18:15:29 GMT
Received: (from news@localhost)
	by niobium.hgmp.mrc.ac.uk (8.9.3+Sun/8.8.8) id SAA07503
	for molreps-list@hgmp.mrc.ac.uk; Tue, 30 Nov 1999 18:15:27 GMT
X-Authentication-Warning: niobium.hgmp.mrc.ac.uk: news set sender to <news> using -f
From: "Dr. Wendy A. Warr" <wendy@warr.com>
X-Newsgroups: bionet.molecules.repertoires
Subject: cheminformatics slides
Date: 30 Nov 1999 09:57:04 -0800
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 27
Distribution: world
Message-ID: <3842F3DC.7C9C@warr.com>
To: molreps@hgmp.mrc.ac.uk
Sender: owner-molreps@hgmp.mrc.ac.uk
Precedence: bulk

You must all be back in the office after Thanksgiving! I am already
getting replies about the slides mentioned in my last message. Two
points of clarification:

1. Yes, there are more jobs going than candidates at the moment, and
yes, they tend to learn on the job, but if universities start to train
them, by the time they emerge in 4 years (?) time the whole situation
could be quite different. So the current training situation of "sitting
alonga Nellie" will probably persist.

2. "p.a." in Slide 22 means per annum.

Apologies for duplicate messages.

Wendy


--
Dr Wendy A Warr
Wendy Warr & Associates, 6 Berwick Court
Holmes Chapel, Cheshire CW4 7HZ, England
Tel/fax +44 (0)1477 533837
wendy@warr.com   http://www.warr.com






